|
|
|
| home > white papers > Bringing more control to temperature-sensitive logistics - UPS Supply Chain Solutions |
|
|
 WHITE PAPERS |
|
|
UPS Supply Chain Solutions
|
|
Bringing more control to temperature-sensitive logistics
|
|
By 2016, world sales of cold-chain drugs and biologics such as vaccines
and blood plasma products will near $240 billion1. The increase has led
to a surge in discussion about how to protect these products throughout
the transportation logistics cycle. Industry experts are recommending
that the term “cold chain” be eliminated from rules, guidance and
best-practice documents. “Cold chain” now includes a broader spectrum of temperature ranges, such as controlled room
temperature (CRT). This white paper focuses on the initial steps
required to establish a temperature-sensitive supply chain.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Saneca Pharma strengthens senior team
Slovakia-based CDMO adds senior talent to its team to position the
company for continued growth
More info >> |
|
 |
White Papers |
 |
|
Value-Added Processing and Quality By Design Principles Help Meet High-Quality Demands
West Pharmaceutical Services, Inc.
The current pharmaceutical market has faced a variety of challenges, including increasing expectations for quality from end-users and regulatory agencies driven by concern for patient safety. While pharmaceutical companies are working to assure that new quality and compliance paradigms are met, a balance must be achieved between the reality of managing costs in an effort to provide a product that meets the requirements of payers along with facilitating profitability in order to continue adequate business reinvestment.
More info >> |
|
 |
Industry Events |
 |
BioProcess International Conference & Exhibition (BPI)
25-28 September 2017, Hynes Convention Center, Boston, Massachusetts, USA
BioProcess International
Conference & Exhibition (BPI) is
the largest bioprocessing event bringing you the science, technologies and
partners needed to accelerate promising biologics towards commercial
success.
More info >> |
|
|
|
